Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lexaria Bioscience (LEXX) Inventory Average (2016 - 2023)

Lexaria Bioscience's Inventory Average history spans 8 years, with the latest figure at $8762.0 for Q1 2023.

  • Quarterly results put Inventory Average at $8762.0 for Q1 2023, down 49.7% from a year ago — trailing twelve months through Feb 2023 was $8762.0 (down 49.7% YoY), and the annual figure for FY2022 was $34033.0, down 53.54%.
  • Inventory Average for Q1 2023 was $8762.0 at Lexaria Bioscience, down from $24177.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $157835.5 in Q3 2019 to a low of $8762.0 in Q1 2023.
  • The 5-year median for Inventory Average is $65607.5 (2021), against an average of $78209.3.
  • The sharpest move saw Inventory Average soared 113.16% in 2019, then plummeted 73.45% in 2022.
  • Year by year, Inventory Average stood at $130476.0 in 2019, then tumbled by 57.54% to $55402.0 in 2020, then crashed by 70.61% to $16281.0 in 2021, then skyrocketed by 48.5% to $24177.0 in 2022, then plummeted by 63.76% to $8762.0 in 2023.
  • According to Business Quant data, Inventory Average over the past three periods came in at $8762.0, $24177.0, and $39300.5 for Q1 2023, Q4 2022, and Q3 2022 respectively.